BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Investor
DBV Technologies Announces Proposed Global Offering 10/20/2014
Exclusive: Fewer Deals, Capital In Biotech In Q3 But Sector Remains Popular, Says VC 10/20/2014
Full Blow Ebola Epidemic Unlikely In U.S., Says Specialist 10/20/2014
Current Climate The Best For Biotech IPOs In Decades, Says VC 10/20/2014
Acasti Pharma Announces Grant Of Stock Options 10/20/2014
AbbVie (ABBV) Still A Buy Despite Shire Fallout, Says Analyst 10/17/2014
Cowen and Company: Best Buys, Favorable Biotech Outlook Remain 10/17/2014
TetraPhase Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock 10/17/2014
Sunshine Biopharma, Inc. Retains Renmark Financial Communications To Provide Investor Relations 10/17/2014
Celator Pharmaceuticals, Inc. Announces Public Offering Of Common Stock And Warrants To Purchase Common Stock 10/17/2014
VG Life Sciences, Inc. (VGLS) Announces Upgrading To OTCQB Marketplace 10/17/2014
TiGenix Publishes Transparency Notification Pursuant To Article 14 Of The Law Of May 2, 2007 10/17/2014
Agios Pharmaceuticals (AGIO) Smart Buy Ahead Of Cancer Data: Citi 10/16/2014
Relmada Therapeutics Reinforces Balance Sheet With $15.2 Million From Exercise Of Warrants 10/16/2014
Relypsa, Inc. (RLYP) Announces New Employment Inducement Grants 10/16/2014
Portage Completes Non-Brokered Private Placement For A Total Proceeds Of US$2,000,000 10/16/2014
Ligand Pharmaceuticals Inc. (LGND) To Host Analyst Day On November 18th In New York City 10/16/2014
Esperion Therapeutics, Inc. (ESPR) Prices Public Offering Of Common Stock 10/16/2014
Nasdaq Welcomes Atara Biotherapeutics (ATRA) To The Nasdaq Stock Market 10/16/2014
TetraPhase Pharmaceuticals Announces Proposed Public Offering Of Common Stock 10/16/2014
Anatara Lifesciences Successfully Lists On The ASX 10/16/2014
Roche (RHHBY) Delivers Solid Sales Growth For The First Nine Months Of 2014 10/16/2014
Medivir AB (MVRBF): Optimization Of Capital Structure 10/16/2014
Roche (RHHBY) Lucentis, Regeneron (REGN) Eylea Continue To Battle It Out In Eye Market 10/16/2014
Tianyin Pharmaceutical Co, Inc. Provides Update On Filing Of Form 10-K For Fiscal Year Ended June 30, 2014 10/15/2014
Orexo AB (ORXOF) Appoints Nomination Committee And Publishes Financial Calendar 2014/2015 10/15/2014
Announcement Regarding Submission Of Tender Offer For Shares In Ambit Biosciences 10/15/2014
UBS: Gilead Sciences, Inc. (GILD) Remains Solid Buy Despite Irish Tax Changes, Price War 10/15/2014
Merck & Co. (MRK) Announces Pricing Of Tender Offers For Eight Series Of Notes 10/15/2014
Esperion Therapeutics, Inc. (ESPR) Announces Proposed Public Offering Of Common Stock 10/15/2014
Nasdaq Welcomes Forward Pharma (FWP) To The Nasdaq Stock Market 10/15/2014
Walking Dead: Biotech "Zombie" Companies And Why They Are Failing 10/15/2014
Selecta Biosciences, Inc. Announces More Than $20 Million In Equity Funding 10/15/2014
ChrysCapital In Talks With Private Equity Firms To Sell 11% In Mankind Pharma 10/15/2014
VG Life Sciences, Inc. (VGLS) Announces SEC Form 10 Review Complete 10/15/2014
Neptune Technologies & Bioressources Inc. Announces Normal Course Issuer Bid 10/15/2014
Tauriga Sciences Inc. (TAUG) Completely Free Of Convertible Debt 10/15/2014
Transcept Pharmaceuticals, Inc. (TSPT) Declares Special Dividend Of $12.79 Million And Additional Contingent Future Amounts In Connection With Its Merger With Paratek Pharmaceuticals, Inc. 10/15/2014
ContraVir Pharmaceuticals Closes $9.0 Million Financing To Advance Lead Shingles Candidate 10/15/2014
Sensient Technologies Corporation Announces Conference Call 10/15/2014
Immunodiagnostic Systems Holdings plc Trading Update 10/14/2014
Preliminary Q3 2014 Report: CytoSorbents, Inc. Achieves Its First Quarter of Approximately $1M in CytoSorb® Sales and Provides Up-listing Update 10/14/2014
Easton Pharmaceuticals (OP: EAPH) Secures Financing Commitment Towards Closing Of Its Option On Canadian Medical Marijuana Facility And Business 10/14/2014
Oxford BioMedica PLC (OXB.L) Director's Share Purchase 10/14/2014
New Irish Tax Rules Won’t Faze Biotech: Analyst 10/14/2014
Sunshine Biopharma, Inc. Retains Renmark Financial Communications To Provide Investor Relations 10/14/2014
Nextech Venture Invest Announces First Closing Of Oncology Fund IV 10/14/2014
Cytori Therapeutics, Inc. (CYTX) Announces Closing Of Financing 10/13/2014
Analysts: Harvoni News Nothing But Upside For Gilead Sciences, Inc. (GILD) 10/13/2014
Spinal Atrophy Drug From Isis Pharmaceuticals, Inc. (ISIS) Showing Promise, Says UBS 10/13/2014
Repligen Corporation (RGEN) To Host Investor & Analyst Event On October 16 10/13/2014
Kythera Biopharmaceuticals (KYTH) Grants Stock Options Under Inducement Program 10/13/2014
Chimerix, Inc. (CMRX) To Webcast R&D Update On October 15th 10/13/2014
Bristol-Myers Squibb Company (BMY) To Hold Investor Teleconference To Discuss CMSTO Highlights 10/13/2014
BioSpace's List Of The Top 5 Biggest VC Vampires In Biotech 10/10/2014
Synthetic Biologics, Inc. (SYN) To Raise $20.7 Million In Registered Direct Offering 10/10/2014
PTC Therapeutics, Inc. (PTCT) Announces Pricing Of Public Offering Of Common Stock 10/10/2014
DiaGenic ASA: Ex Right To Receive Subscription Rights In The Rights Issue Today, 10 October 2014 10/10/2014
Anacor Pharmaceuticals, Inc. (ANAC) Announces Pricing Of Offering Of $75 Million Of 2.00% Convertible Senior Notes Due 2021 10/10/2014
MabVax Therapeutics, Inc. Announces Stock Ticker Symbol Change To MBVX 10/10/2014
PRAC Decision On Leukemia Drug Good News For Ariad Pharmaceuticals, Inc. (ARIA), Says Analyst 10/10/2014
CPhI Panel Warns ‘Commitment Dilution’ Hindering Drug Development And Price Pressure Compromising Safety 10/9/2014
Gilead Sciences, Inc. (GILD) Will Have Higher Revenues, EPS On Liver Drug Strength: Citi 10/9/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 10/9/2014
Cross-Over Investing All The Rage, Say VCs On Panel 10/9/2014
Skyepharma PLC (SKYEF) – Interim Management Statement 10/9/2014
PTC Therapeutics, Inc. (PTCT) Announces Proposed Public Offering Of Common Stock 10/9/2014
Arrowhead Research Corporation (ARWR) Issues Open Letter To Shareholders 10/9/2014
AVANIR Pharmaceuticals (AVNR) To Host Investor Briefing On October 15, 2014 10/9/2014
Anacor Pharmaceuticals, Inc. (ANAC) Announces Proposed Offering Of $70 Million Of Convertible Senior Notes Due 2021 10/9/2014
Traders’ Infatuation With Ebola Drugs Causing “Rollercoaster” Market, Says Tekmira (TKMR) CEO 10/8/2014
Cytori Therapeutics, Inc. (CYTX) Raises $13.5 Million In Registered Direct Offering 10/8/2014
Sand Hill Angels Continues To Invest In Mobile And The Cloud Participating In Perkville's $2.4 Million Dollar Series A 10/8/2014
Medivir AB (MVRBF) Capital Markets Meeting on 16 October 2014 10/7/2014
Radius (RDUS) Announces Closing Of Public Offering Of Common Stock And Partial Exercise Of Underwriters' Option To Purchase Additional Shares 10/7/2014
Therapix Biosciences ADRs Begin Trading On The OTCQB® 10/7/2014
Asterias Biotherapeutics To List Its Series A Common Stock On NYSE MKT 10/7/2014
Cellular Biomedicine Group (CBMG) Calls For General Annual Stockholder Meeting On November 07, 2014 10/7/2014
BioDelivery Sciences International (BDSI) To Provide BUNAVAIL Launch Update 10/7/2014
Avidity NanoMedicines Expands Investor Syndicate 10/7/2014
Oncologix Tech, Inc.  (OTCBB: OCLG) Continues Debt Reduction Strategy; Strengthens Company's Stock Position And Shareholder Value 10/7/2014
Exostar Obtains $5 Million Investment For Their Growing Healthcare Business 10/7/2014
Retrophin (RTRX) Booted CEO For Multiple Stock Violations: Report 10/6/2014
Agios Pharmaceuticals (AGIO) To Webcast R&D Day On October 15, 2014 10/6/2014
Pivotal Therapeutics Inc. Announces Payment Of Interest On Outstanding Convertible Notes 10/6/2014
LabStyle Innovations Implements 1-For-5 Reverse Stock Split 10/6/2014
Cord Blood America, Inc. Announces Divestiture Of Biocordcell Argentina, S.A. 10/6/2014
Medtech Startup Embo Medical Secures €3 Million Investment 10/6/2014
iBio, Inc. (IBIO) Reports On Filing Of 2014 Annual Report 10/6/2014
Vitrolife (VITR.ST): Invitation To Capital Markets Day On November 6 10/6/2014
Merck & Co. (MRK) Announces Tender Offers For Eight Series Of Notes 10/6/2014
Merck & Co. (MRK) Announces Proposed Public Debt Offering 10/6/2014
Piper Jaffray: Companies Should Start Stockpiling Now For Ebola 10/3/2014
Venture Capital Pours Into Biotech For Biggest Quarter Since 2012: Report 10/3/2014
Salix Pharmaceuticals, Ltd. (SLXP) To Ring The Nasdaq Stock Market Closing Bell 10/3/2014
Portola Pharmaceuticals, Inc. Announces Pricing Of Public Offering Of Common Stock 10/3/2014
Vital Therapies, Inc. (VTI) (VTL) Announces Pricing Of Follow-On Offering 10/3/2014
Mylan Inc. (MYL) Increases Third Quarter And Full Year 2014 Adjusted Diluted EPS Guidance Range 10/3/2014
Sevion Therapeutics Announces New Ticker Symbol “SVON” 10/3/2014
Opexa Therapeutics (OPXA) Announces Analyst And Investor Event 10/3/2014
Antibe Therapeutics Inc. Reports on Results of AGM Voting 10/3/2014
Retrophin (RTRX) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 10/3/2014
Biotech Boom On Third Coast Proves Everything's Bigger In Texas 10/3/2014
Radius (RDUS) Announces Pricing Of Public Offering 10/2/2014
Veracyte, Inc. (VCYT) To Host Investor Day On October 9, 2014 10/2/2014
Chimerix, Inc. (CMRX)’s Brincidofovir An Ebola Standout For Traders, Says Analyst 10/2/2014
ISS Urges Allergan Inc. (AGN) To Give Investors Vote, Questions Credibility 10/2/2014
Radius (RDUS) Announces Proposed Public Offering 10/2/2014
JSS Medical Research Announces Equity Investment By Capital Croissance PME (CCPME) 10/2/2014
Portola Pharmaceuticals, Inc. Announces Proposed Offering Of Common Stock 10/2/2014
Resverlogix Corporation (RVX.TO) Corporate Update Conference Call & Webcast Announcement 10/2/2014
Momenta Pharmaceuticals, Inc. (MNTA) To Host 2014 R&D Day 10/2/2014
Pfenex Inc. (PFNX) Added To Both Russell Microcap® Index And Russell Global Indexes 10/2/2014
Lightlake Therapeutics Inc. (LLTP) Announces Closing Of Investments In Two Products 10/2/2014
Aptose Biosciences Announces Reverse Stock Split 10/2/2014
Perrigo Company (PRGO) Announces Expiration Of Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043 10/2/2014
H&Q Life Sciences Investors Pays Stock Distribution 10/1/2014
Conversion Right Triggered for Laboratory Corporation of America Holdings (LabCorp) (LH)’s Zero Coupon Convertible Subordinated Notes Due 2021 10/1/2014
Ardelyx Inc. (ARDX) Looks Good After Tenanpanor Results: Citi Analysts 10/1/2014
Abstracts For Merck & Co. (MRK), Gilead Sciences, Inc. (GILD) And AbbVie (ABBV) Look Promising, Says ISI 10/1/2014
Vital Therapies, Inc. (VTI) (VTL) Announces Launch Of Proposed Follow-On Offering 10/1/2014
Otonomy, Inc. (OTIC) Added To Russell 2000® Index 10/1/2014
Assembly Biosciences Announces $15.75 Million Registered Direct Offering 10/1/2014
Perrigo Company (PRGO) Announces Extension Of Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043 10/1/2014
Aerie Pharmaceuticals, Inc. (AERI) Announces Closing Of $125 Million Convertible Notes Financing 10/1/2014
BrainStorm Cell Therapeutics Inc. Completes Uplisting To The NASDAQ Capital Market 10/1/2014
If Allergan Inc. (AGN) Survives Valeant (VRX), AbbVie (ABBV), Shire or Actavis (ACT)/Forest May Be Suitors 9/30/2014
Portage Announces Conversion Of Its Debt Into Equity 9/30/2014
Catabasis Pharmaceuticals, Inc. Management To Present At October Investor Conferences 9/30/2014
TNI BioTech's CEO Issues Letter To Shareholders Discussing Cytocom Dividend 9/30/2014
Allergy Therapeutics plc Release: Amendment Of 2012 Loan Note Term 9/30/2014
Pfizer (PFE) Will Wait Out Midterm Elections For Favorable Inversion Laws: Analyst 9/30/2014
Alimera Sciences (ALIM) Provides Details On FDA Approval Of Iluvien® As The First Long-Term Treatment For Diabetic Macular Edema 9/29/2014
BioTie Therapies Corp.'s Financial Information In 2015 9/29/2014
Tesaro, Inc. (TSRO) Announces Closing Of $201.25 Million Public Offering Of 3.00% Convertible Senior Notes Due 2021, Including Full Exercise Of The Underwriters' Option To Purchase Additional Notes 9/29/2014
"Cascade” Of Biotech M&A Will Transform Specialty Pharma: Cowen 9/29/2014
Analysts Say Valeant Pharmaceuticals International (VRX)/Allergan Inc. (AGN) Deal Could Lead To Buying Spree 9/29/2014
Roche (RHHBY) Purchases Shares In Tender Offer For InterMune, Inc. (ITMN) 9/29/2014
Lpath, Inc. (LPTN) Announces Closing of $12.5 Million Registered Direct Offering 9/29/2014
Agrisoma Biosciences Inc. Announces Closing Of Series A Round 9/29/2014
RXi Pharmaceuticals (RXII) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/29/2014
AVANIR Pharmaceuticals (AVNR) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/29/2014
NeoStem, Inc. Secures Debt Facility 9/29/2014
GW Pharmaceuticals Research And Development Day Details 9/29/2014
Asterias Biotherapeutics Announces Distribution Date Of Biotime Warrants And Conversion Date Of Series B Common Stock Into Series A Common Stock 9/29/2014
Gilead Sciences, Inc. (GILD)'s Harvoni Will Fast Track: Analyst 9/26/2014
AVEO Oncology (AVEO) Terminates Cambridge Lease Agreement To Save $110 Million 9/26/2014
Amarantus BioSciences, Inc. Shareholders Approve All Matters Voted Upon At Annual Shareholders Meeting 9/26/2014
Galena Biopharma  (GALE) Announces Release Of Special Committee Report And Hosting Of A Conference Call To Provide A Corporate Update 9/26/2014
Karyopharm Therapeutics (KPTI) To Host Conference Call To Discuss Selinexor (KPT-330) Data Presented At ESMO 2014 9/26/2014
HEALTHSOUTH Announces Date Of 2014 Third Quarter Earnings Conference Call 9/26/2014
Pentwater Capital Management Issues Letter To Board Of Directors Of Allergan Inc. (AGN) 9/26/2014
China Cord Blood Corporation To Hold Annual General Meeting In Hong Kong On December 11, 2014 9/26/2014
Cellceutix (CTIX) Provides Update To Shareholders 9/26/2014
Analyst: Novartis AG (NVS), Celgene (CELG) Might Go Toe-to-Toe Over Psoriasis Drugs 9/26/2014
Allergan Inc. (AGN) Issues Statement Regarding Recent Valeant Pharmaceuticals International (VRX) Correspondence 9/25/2014
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 9/25/2014
Regeneus (RGS.AX) (ASX:RGS) Receives R&D Tax Incentive Refund Of $3.7 Million 9/25/2014
Antisense Therapeutics Limited (ANP.AX) Release: Placement And Share Purchase Plan 9/25/2014
Baxter International, Inc. (BAX)'s Deal With Merrimack Pharmaceuticals Inc. (MACK) All Upside: Analyst 9/24/2014
Analysts Say ZS Pharma (ZSPH) Continues To Gain On Drug Approval 9/24/2014
ProQR Therapeutics B.V. (PRQR) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/24/2014
Lipocine Inc. (LPCN) To Host Conference Call And Webcast To Discuss Top-Line Results From The Phase 3 Study Of LPCN 1021 9/24/2014
Hyperion Therapeutics (HPTX) To Host Analyst Day September 30, 2014 9/24/2014
Tesaro, Inc. (TSRO) Announces Pricing Of $175 Million Of 3.00% Convertible Senior Notes Due 2021 9/24/2014
Intellect Neurosciences, Inc. Issues Letter To Shareholders 9/24/2014
TNI BioTech Announces Its Stock Is Now DTC DWAC/FAST Eligible 9/24/2014
AVANIR Pharmaceuticals (AVNR) Announces Pricing Of Public Offering Of Common Stock 9/24/2014
Expiration of the U.S. Tender Offer For CFR Pharmaceuticals 9/24/2014
Valeant Pharmaceuticals International (VRX) Provides Update On Third Quarter Results And Sends Letter To Allergan Inc. (AGN) CEO And Lead Independent Director 9/24/2014
Clinigen Release: Underlying EBITDA Up 19.8% And EPS Up 22% 9/24/2014
The Medicines Company (MDCO) To Webcast Infectious Disease Care Investor & Analyst Day On September 24 9/24/2014
TAP Biosystems Release: New Webinars Explore Feed Strategy Challenges Using Mini Bioreactors 9/24/2014
Hurel Corporation Completes Investment From Johnston Associates, Inc. 9/24/2014
Hurel Corporation Completes Investment from Johnston Associates, Inc. 9/24/2014
What Happened At BioPharm America 2014? 9/24/2014
Analysts: New Inversion Rules Won't Scuttle Mylan Inc. (MYL), Medtronic Limited (MDT) Deals 9/23/2014
Analysts Say Biogen Idec, Inc. (Massachusetts) (BIIB) Must Push Into Gene Therapy To Stay Competitive 9/23/2014
Tesaro, Inc. (TSRO) Announces Offering Of $165 Million Of Convertible Senior Notes Due 2021 9/23/2014
Supernus Pharmaceuticals (SUPN) Provides Business Update 9/23/2014
AVANIR Pharmaceuticals (AVNR) Announces Proposed Public Offering Of Common Stock 9/23/2014
Inivata Raises £4m To Realise The Potential Of Ctdna Analysis To Improve Cancer Treatment Through Simple Blood Tests 9/23/2014
Xenetic Biosciences To Hold Business Update Conference Call September 23 At 6:00 A.M. Eastern Time 9/23/2014
NetScientific plc Release: Half-Yearly Report 9/23/2014
Pfizer (PFE) Invites Public To View And Listen To Webcast Of October 28 Conference Call With Analysts 9/23/2014
Cellectis (ALCLS): Individual Shareholder Meeting 9/23/2014
TapImmune Inc. (TPIV) CEO Provides Update On Corporate Activity And Progression Of Clinical Programs 9/23/2014
Biogen Idec, Inc. (Massachusetts) (BIIB) Named Global Biotechnology Industry Leader On Dow Jones Sustainability World Index 9/23/2014
Wall Street Overreacting To Inversion Proposals, Says ISI Group 9/23/2014
Transition Therapeutics Inc. (TTH.TO) To Hold Conference Call On Full Year Fiscal 2014 Financial Results On Thursday, September 25th, At 4:30 P.M. EST 9/22/2014
Xstelos Announces Intention To Vote Against Affymax, Inc. (AFFY)'s Plan Of Liquidation At September 23, 2014 Special Meeting of Shareholders 9/22/2014
Skyepharma PLC (SKYEF) Announces Notice Of Early Repayment Of Euro CRC Facility 9/22/2014
Nordic Nanovector: Registered Share Capital Increase 9/22/2014
Xenetic Biosciences To Hold Business Update Conference Call September 23 At 6:00 A.M. Eastern Time 9/22/2014
Onxeo Attends InvestorDagen 2014, The Largest Danish Private Investor Event 9/22/2014
Aratana Therapeutics (PETX) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/19/2014
Lpath, Inc. (LPTN) Announces $12.5 Million Registered Direct Offering 9/19/2014
DiaGenic ASA – Notice Of Extraordinary General Meeting 9/19/2014
ICON Plc Announces Completion Of $40 Million Share Buyback And A Further Share Buyback Program For Up To $100 Million 9/19/2014
PharMerica Announces New Senior Secured Credit Agreement 9/19/2014